Status:

TERMINATED

Attention Training on Smartphones

Lead Sponsor:

University of Florida

Conditions:

Attention

Substance Use

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

The goal of this study is to evaluate a new method that may influence attention, cravings and substance use called attention training, which will be delivered on a smartphone through an application (a...

Detailed Description

The goal of this study is to evaluate a new method that may influence attention, cravings and substance use called attention training, which will be delivered on a smartphone through an application (a...

Eligibility Criteria

Inclusion

  • Able to read and write in English fluently and complete study evaluations
  • 6-week availability to participate in the study
  • Willing and able to answer questions on smartphones up to 4 times daily for about 10 minutes each time.
  • On Suboxone (or methadone if recruitment does not progress as planned) for at least one month (verified by urine drug test- unless using transdermal patch because 1/3 of patients using the patch will not show positive urine screen; and verified by opioid replacement therapy-provider)"
  • Meet DSM-5 criteria for opioid use disorder

Exclusion

  • Use (outside of prescription) for drugs that negatively interact with one another
  • Meet severe DSM-5 criteria for current substance use disorders other than opioids, nicotine or cannabis (e.g., current stimulant use disorder) and have used that substance within the past 30 days based on self-report or a positive urine drug test
  • Severe psychiatric conditions
  • Color blindness and/or uncorrected defective vision

Key Trial Info

Start Date :

September 1 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 17 2023

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT04097340

Start Date

September 1 2019

End Date

June 17 2023

Last Update

September 3 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

EDGE Laboratory

Gainesville, Florida, United States, 32611